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Abstract
Background/Aim: Nitric oxide (NO) modulates the ex-
pression of the chaperone Hsp72 in the heart, and
exercise stimulates both NO production and myocar-
dial Hsp72 expression. The main purpose of the study
was to investigate whether NO interferes with an ex-
ercise-induced myocardial Hsp72 expression. Meth-
ods: Male Wistar rats (70-100 days) were divided into
control (C, n=12), L-NAME-treated (L, n=12), exer-
cise (E, n=13) and exercise plus L-NAME-treated (EL,
n=20) groups. L-NAME was given in drinking water
(700 mg.L-1) and the exercise was performed on a
treadmill (15-25 m.min-1, 40-60 min.day-1) for seven
days. Left ventricle (LV) protein Hsp content, NOS
and phosphorylated-NOS (p-NOS) isoforms were
measured using Western blotting. The activity of NOS
was assayed in LV homogenates by the conversion
of [3H]L-arginine to [3H]L-citrulline. Results: Hsp72
content was increased significantly (223%; p<0.05)
in the E group compared to the C group, but exercise
alone did not alter the NOS content, p-NOS isoforms
or NOS activity. Contrary to our expectation, L-NAME
enhanced (p<0.05) the exercise-induced Hsp72 con-
tent (EL vs. C, L and E groups = 1019%, 548% and
457%, respectively). Although the EL group had in-
creased stimulatory p-eNOSSer1177 (over 200%) and
decreased inhibitory p-nNOSSer852 (~50%) compared
to both the E and L groups (p<0.05), NOS activity
was similar in all groups. Conclusions: Our results
suggest that exercise-induced cardiac Hsp72 expres-
sion does not depend on NO. Conversely, the in vivo
L-NAME treatment enhances exercise-induced Hsp72
production. This effect may be due to an increase in
cardiac stress.
Introduction
It has been clearly established that exercise training
reduces the risk of ischemic cardiac diseases. This
cardioprotection seems to depend at least in part on the
increased expression of several proteins known as stress
proteins which maintain cellular homeostasis under stress-
ful conditions [1, 2]. Overexpression of the heat shock
protein-72 (Hsp72), a stress protein, seems to play a critical
role for the exercise-induced cardioprotection [1, 2]. In-
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creased body temperature [3], mechanical stress [4], free
radicals [5], intracellular Ca2+ [6] and adrenergic stimu-
lation [7] are hypothesized as putative mechanisms that
increase Hsp72 expression during exercise. However, the
molecular mechanisms linking exercise to the increased
cardiac Hsp72 expression remain unknown.
Malyshev et al. reported that the nitric oxide (NO)
is involved in the cardiac Hsp72 expression cascade be-
cause its expression was attenuated in presence of NO
synthase (NOS) inhibition in rats submitted to heating [8].
Xu et al. also observed that Hsp72 expression is NO-
dependent in cultured vascular smooth muscle cells [9].
Similar findings have been observed in intestinal epithe-
lial T84 cells [6]. Direct and indirect effects of NO on
the heat shock factor-1 (HSF1) have been speculated to
be the causal mechanism of the NO-induced Hsp72
overexpression [6, 8, 9].
NO is a free radical with a half-life of few seconds.
It is produced in almost all cardiac cells. This small and
highly diffusible molecule acts as an important intra- and
intercellular messenger by modulating the activation of
protein kinases A and C [10, 11], which are also involved
in Hsp72 expression [12-14]. Aside from increasing body
temperature, exercise elevates myocardial NO produc-
tion by increasing NOS expression [15, 16] and shear
stress-induced NO production in the coronary vessels
[17]. Since exercise represents a stress condition to the
heart, it is conceivable that the increased NO production
may also contribute to stimulate Hsp72 production during
exercise.
In a previous study [18], however, NOS inhibition
with Nω-nitro-L-arginine methyl ester (L-NAME) did not
prevent the exercise-induced Hsp72 expression in the
cardiac muscle of rats. However, in this study, Hsp72
expression was measured in rats submitted to the in vitro
ischemia-reperfusion which can also influence per se Hsp
72 expression. Moreover, NOS activity and expression
were not evaluated in this study. Because in vivo L-
NAME treatment may induce compensatory NOS-de-
rived NO in the rodent heart [19-21], it is essential to
measure either cardiac NOS expression as activity to an
adequate evaluation of the potential participation of NO
in exercise-induced cardiac Hsp72 expression.
Therefore, our aim was to investigate the possible
participation of NO for the exercise-induced myocardial
Hsp72 content in the rat. Contrary to our expectation,
our results showed that, although the L-NAME treat-
ment does not alter left ventricle (LV) NOS activity, it




All animal experiments were approved by the Institutional
Ethics Committee at the Federal University of Espírito Santo,
Brazil (protocol 003/2009).
Groups and treatment
Male Wistar rats (70 to 100 days old) were used in this
study. The animals were housed in collective cages (n = 4-5 per
cage) to prevent the well-known stressful situation induced by
socially isolated rats [22]. The animals were maintained in a
temperature-controlled room (22-25ºC) under a 12:12-h light:dark
cycle with free access to water and rat chow. One week before
experimentation, all animals were subjected to a treadmill exer-
cise test (15 m.min-1, 10 min, 0% grade) to evaluate running
ability. The rats that completed this preliminary exercise ses-
sion were randomly divided into four experimental groups: con-
trol (C; n = 12), L-NAME (L; n = 12), exercise (E; n = 13) and
exercise plus L-NAME (EL; n = 20). This selection strategy is
necessary because rats with different intrinsic aerobic exercise
capacity show unequal cardiomyocyte properties [23]. The L
and EL groups received L-NAME continuously (Sigma Aldrich,
St. Louis, MO, USA) dissolved in drinking water (700 mg.L-1)
for seven days. This L-NAME concentration was similar to
that used in other studies [24, 25]. Water intake was measured
daily by dividing the total consumption by the number of rats
in each cage. Animals from the E and EL groups were simulta-
neously subjected to a short-term treadmill running protocol
for seven days. During the first four days these animals ran
daily for 60, 60, 40 and 60 min.set-1 at treadmill speeds of 15, 18,
20 and 20 m.min-1, respectively, 0% grade, to adapt to the
running protocol. For the following three days, animals ran
daily for 40, 60 and 40 min.set-1 at speeds of 22.5, 22.5 and 25
m.min-1, respectively, 0% grade. The C and L groups remained
sedentary during the experimental period.
Haemodynamic measurements
Seven days after L-NAME treatment and 24 h after the
final exercise session, the animals were anesthetized with
ketamine plus xylazine (90 mg.kg-1 and 10 mg.kg-1, respectively,
i.p.), and a fluid-filled polyethylene catheter (PE-50, 10-15 cm)
was introduced in the right carotid artery to assess arterial
pressure during spontaneous breathing. After a stabilization
period, the catheter was inserted into the LV cavity to record
the LV systolic and end-diastolic pressures and their first posi-
tive and negative maximal time derivatives (+dP/dt and -dP/dt).
Arterial and ventricular pressures were recorded continuously
for at least 20 min using a pressure transducer (TRA021, LSI,
Letica Scientific Instruments, Spain) connected to a data acquisi-
tion system (Powerlab 4sp, sp-4922, ADInstruments, Australia).
Haemodynamic parameters from each rat were calculated as
mean values from each 20-min record under stable conditions
(Chart 5 PRO software, ADInstruments, Australia). The ani-
mals were then euthanized and the heart and right tibia were
removed. The LV and right ventricle (RV) were weighed and its
fragments were stored at -80ºC. The length of the right tibia
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(mm) was measured with a paquimeter and later it was used to
obtain ventricles weight index (ventricle weight/right tibia
length).
Western blot procedures to assess total NOS, phosphor-
ylated-NOS (p-NOS), Hsp72 and Hsp73 content
Western blots for eNOS, nNOS, iNOS and p-NOS (p-
eNOSThr495 and p-eNOSSer1177; p-nNOSSer852) were performed as
previously described [26]. Briefly, LV fragments were lysed at
4°C with lysis buffer solution (in mmol/L: 150 NaCl, 50 Tris-
HCl, 5 EDTA.2Na, and 1 MgCl2) containing 1% Triton X-100,
0.5% SDS plus a cocktail of protease inhibitors (SigmaFAST).
Phosphatase inhibitors were used (NaF 20 mM; Na3VO4 0.1
mM) in the determination of phosphorylated proteins. The
lysate was centrifuged, and the protein concentration in the
supernatant was determined spectrophotometrically. Thirty µg
were separated using a denaturing SDS polyacrylamide gel
(7.5 or 15%) and transferred to a polyvinylidene difluoride
(PVDF) membrane (Millipore). Blots were blocked with 5% non-
fat dry milk in PBS and 0.1% Tween 20 (PBS-T) at room tem-
perature. The following antibodies (Santa Cruz Biotechnology,
Santa Cruz, CA) were used: rabbit polyclonal anti-eNOS
(1:1,000), rabbit polyclonal anti-nNOS (1:1,000), rabbit
polyclonal anti-iNOS (1:1,000), goat polyclonal anti-p-
eNOSSer1177 (1:1,000), goat polyclonal anti-p-eNOSThr495 (1:1,000),
goat polyclonal anti-p-nNOSSer852 (1:1,000) and mouse
monoclonal anti-β-actin (1:3,000). Immunocomplexes were de-
tected using a chemiluminescent reaction (ECL kit; Amersham,
Les Ulis, France) followed by densitometric analyses with the
ImageQuant software package. β-Actin content was used to
normalize total NOS protein content.
For Hsp72 and Hsp73 western blotting, LV samples were
pulverized in liquid nitrogen using a mortar (Fisher Scientific,
USA) and then homogenized in ice-cold buffer (600 mM NaCl,
15 mM Tris-HCl, 1 mM PMSF, pH 7.5) as previously described
[27]. After 5 min on ice, homogenized tissues were centrifuged
(14,000 g, 20 min, 4°C), and the protein concentration in the
supernatant was determined using Bradford reagent (Bio-Rad,
USA). Protein extracts (75 µg) were electrophoretically sepa-
rated by 7.5% SDS-PAGE for ~20 h at 40 V in running buffer (25
mM Tris, 190 mM glycine, 0.05% SDS). Proteins were then
transferred to PVDF membranes (Amersham, USA) using a
Trans-Blot cell system (Bio-Rad, USA) in buffer (25 mM Tris,
190 mM glycine, 20% methanol, 0.05% SDS). Membranes were
blocked with 5% non-fat dry milk and then incubated in
monoclonal anti-HSP 70 (1:1,000, Sigma-Aldrich), which recog-
nizes both Hsp72 and Hsp73, for ~12 h at 4°C. After washing
(10 mM Tris, 100 mM NaCl, 0.1% Tween 20), the membranes
were incubated in peroxidase-conjugated goat anti-mouse IgG
(1:2,000, Bio-Rad, USA). Immunocomplexes were detected us-
ing an enhanced horseradish peroxidase-luminol chemilumi-
nescence system (ECLPlus, Amersham) and subjected to auto-
radiography (Hyperfilm ECL, Amersham). Signals on immuno-
blots were quantified using Scion Image software. Because
stress events only produce a slight increase in Hsp73 expres-
sion that quickly (~4 h) returns to baseline levels [4, 5], total
Hsp73 content was used as an internal control for normalizing
Hsp72 content, as previously published [4]. A positive control
for cardiac Hsp72 was obtained using heart tissue from an
unstressed adult rat that was anesthetized with ketamine plus
xylazine (90 mg.kg-1 and 10 mg.kg-1, i.p.) and warmed to 42 ±
0.4°C (15 min), as previously described [2].
NOS activity
NOS activity was measured using the [3H]L-citrulline as-
say method [28] with slight modifications. LV tissues were sus-
pended in hydroxyethylpiperazine ethanesulphonic acid
(HEPES) buffer (in mM: HEPES 20, sucrose 320, DTT 1, EDTA
1, PMSF 1) and lysed with a sonifier (Thorton). The homo-
genates were centrifuged at 500 g for 10 min at 4ºC. Aliquots
from the supernatant were incubated in HEPES buffer (30 mM,
pH 7.4) containing 1 mM EDTA, 1.25 mM CaCl2, 4 µM FAD, 4
µM FMN, 25 µM 5,6,7,8-tetrahydrobiopterin, 1 mM NADPH,
10 µg.ml-1 calmodulin, 120 nM L-arginine and 0.5 µCi [3H]L-
arginine for 60 min at 37ºC in a total volume of 200 µl. The
reactions were stopped by adding 1 ml of a solution containing
20 mM HEPES, pH 5.5. These samples were passed through a
0.3-ml DOWEX 50WX8-400 (Na+ form) column, and [3H]L-cit-
rulline was eluted with 1 ml HEPES buffer (20 mM, pH 5.5).
Citrulline, ionically neutral at pH 5.5, passes through the col-
umn completely. The radioactivity corresponding to [3H]L-cit-
rulline in the eluate was measured by liquid scintillation count-
ing. Protein concentration was determined by the Bio-Rad pro-
tein assay.
Statistical analysis
Data are presented as means ± SEM. Two-way ANOVA
and Tukey’s post hoc test were used to assess the interaction
between exercise and L-NAME intervention. The Pearson cor-
relation coefficient (r) was used to determine the association
between Hsp72 content and the L-NAME-induced increase in
blood pressure. Statistical significance was set at 5%.
Results
Water intake was higher (p < 0.05) in the C and E
groups (C = 44±1 vs. E = 43±1 mL/day; p > 0.05) than in
the L-NAME-treated groups (L = 34±1 vs. EL = 34±1
mL/day). The L-NAME dose was similar (p > 0.05) in
the two treated groups (around 24 mg/day). L-NAME
treatment reduced the animals’ ability to follow the run-
ning protocol used in our study. Five animals (25%) were
removed from the EL group because they were unable
to complete the running protocol. Another five rats in the
EL group died during the experimental period. Death oc-
curred at night, between the fourth and sixth days of the
running protocol. As 20 rats were included in the EL group,
the results refer to the 10 rats that completed the exer-
cise protocol. Two animals (15%) were also removed
from the E group because they did not tolerate the pro-
gressive exercise protocol. No dropping out occurred in
the C and L groups.
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Body and ventricular weights
Table 1 shows body and ventricular weights and ven-
tricle weights normalized to tibia length. No significant
differences were found in these parameters.
Blood pressure and LV function
Table 2 shows the blood pressure and LV function
data. The L group exhibited a higher blood pressure and
higher LV peak systolic pressure (LVSP) compared
to the C and E groups. In the EL group, we observed
 that exercise prevented the elevation in blood pressure
and LVSP induced by L-NAME. End-diastolic pressure,
heart rate, +dP/dt, and –dP/dt were similar in all four
groups.
NOS and p-NOS content by Western blot
Fig. 1 and 2 show the content of NOS isoforms and
p-NOS isoforms, respectively. Neither exercise nor
L-NAME alone changed total eNOS or iNOS content.
The L group exhibited increased total nNOS content. The
eNOS phosphorylated at the Thr495 inhibition site was
not changed in any group, while the eNOS phosphor-
ylated at the Ser1177 stimulatory site was increased in
the EL group. The nNOS phosphorylated at the Ser852
inhibition site was increased in the L group and decreased
in the EL group.
Total NOS activity
Total NOS activity obtained by measuring the con-
version of [3H]L-arginine to [3H]L-citrulline was similar
in the four groups (Fig. 3).
Heat shock proteins content
Fig. 4 depicts Hsp72 content and the Hsp72/Hsp73
content ratio. As expected, the constitutive content of
cardiac Hsp73 (in arbitrary units – AU) was similar in all
groups (C = 9,838±776, L = 9,635±455, E = 9,13±449 and
EL = 9,765±413). As expected, cardiac Hsp72 and the
Hsp72/Hsp73 content ratio were higher in E group than
in the C group. An interaction was observed in the exer-
cised group subjected to L-NAME treatment (EL group).
Namely, Hsp72 content in the EL group was increased
almost fourfold over its respective control group (E group).
No correlation between Hsp72 content and systolic pres-
sure (r = -0.13; p = 0.6), diastolic pressure (r = -0.05;
p = 0.8) or LVSP (r = - 0.02; p = 0.9) was found.
Discussion
The hypothesis tested in this study was that NO in-
fluences the exercise-induced increase in the content of
myocardial Hsp72. Contrary to our initial expectations,
Table 1. Body weights, visceral weights and tibia lengths in the four experimental groups. BW=body
weight, LVW=left ventricle weight; RVW=right ventricle weight; TL=right tibia length. Data are shown as
mean±SEM, and only animals that completed the experimental protocol were included. ‡, two-way ANOVA.
Table 2. Haemodynamic data for the experimental groups. SAP=systolic arterial pressure; DAP=diastolic
arterial pressure; MAP = mean arterial pressure; HR=heart rate; LVSP=left ventricular peak systolic pres-
sure; EDP=end-diastolic pressure; and dP/dt=1st derivative of left ventricular pressure. Data are presented








L-NAME (EL; n: 10)
Interaction
exercise vs. L-NAME ‡
Initial BW (g) 338±8 348±8 338±6 338±9 p = 0.77
Final BW (g) 369±11 359±11 357±11 346±12 p = 0.94
TL (cm) 3.56±0.03 3.52±0.03 3.53±0.03 3.53±0.03 p = 0.37
LVW (g) 0.74±0.02 0.76±0.02 0.75±0.03 0.76±0.02 p = 0.42
RVW (g) 0.20±0.01 0.22±0.01 0.22±0.01 0.21±0.01 p = 0.06
LVW/TL (g.cm
-1
) 0.211±0.007 0.216±0.006 0.216±0.006 0.209±0.006 p = 0.35
RVW/TL (g.cm
-1








L-NAME (EL; n: 10)
Interaction
exercise vs. L-NAME ‡
SAP (mmHg) 131±5 157±4* 130±5 122±6 p = 0.01
DAP (mmHg) 101±4 124±4* 98±4 94±4 p = 0.01
MAP (mmHg) 112±4 135±5* 109±4 103±4 p = 0.01
HR (bpm) 247±10 237±4 215±10 236±11 p = 0.16
LVSP (mmHg) 133±5 150±5* 135±5 131±5 p = 0.04
EDP (mmHg) 9±1 10±1 10±1 7±1 p = 0.08
dP/dt (mmHg/s) 5406±285 5482±301 4876± 272 5305±301 p = 0.55
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Fig. 2. Content of phosphorylated nitric-oxide synthase (p-NOS) in the left ventricle of rats in the control group (C=not exercised
and not treated with L-NAME), L-NAME-treated group (L group), and untreated exercised group (E group) and L-NAME-treated
exercised (EL group). A.U.=arbitrary units. *, p < 0.05 between groups depicted by a horizontal line. Only statistically relevant
differences to the study purpose are depicted in panels. Data are presented as mean±SEM; two-way ANOVA followed by
Tukey’s post hoc test. The number of samples studied was 5 to 6 per group.
A C
Fig. 3. Conversion of [3H]L-arginine to
[3H]L-citrulline labelled in the left ventricles
of rats. Groups are the same as in Fig. 1. Data
are presented as mean±SEM. p > 0.05, two-
way ANOVA. The number of samples stud-
ied was 6 per group.
B
Fig. 4. Content of Hsp72 and Hsp72/Hsp73 in the left ventricles of rats. Groups
are the same as Fig. 1. A.U. = arbitrary units; C+ = positive control. *, p < 0.05
between groups discriminated by a horizontal line, two-way ANOVA followed by
Tukey’s post hoc test. The number of samples studied was 6 per group.
the use of NOS inhibitor in exercised rats for seven days
produced a substantial increase in cardiac Hsp72 con-
tent. The rat model was used in our experiments because
the exercise effects on Hsp72 induction in well known in
this rodent model [8, 14, 16, 18].
The rationale for our original hypothesis came from
L-NAME Enhances Exercise-induced Myocardial Hsp72 Content Cell Physiol Biochem 2011;27:479-486
Fig. 1. Nitric oxide synthase (NOS) content in the left ventricle of rats in the control group (C=not exercised and not treated with
L-NAME), L-NAME-treated group (L group), untreated exercised group (E group) and L-NAME-treated exercised (EL group).
A.U.=arbitrary units. *, p < 0.05 between groups depicted by a horizontal line. Data are presented as mean±SEM; two-way
ANOVA followed by Tukey’s post hoc test. The number of samples studied was 5 or 6 per group.
A B C
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a previous study showing that NO enhances heat shock-
induced expression of Hsp72 in the heart [8]. In vitro
studies confirmed the importance of the NO in heat
shock-induced expression of Hsp72 [6, 9]. Exercise may
also induce cardiac Hsp72 expression by increasing body
temperature [3]. However, other pathways may influ-
ence induction of this stress protein during exercise.
Since exercise stimulates cardiac NOS bioavailability [17]
and expression [15, 16] the participation of NO on the
Hsp70 induction during exercise has been proposed [12,
13].
In the present study, total and phosphorylated NOS
and in vitro NOS activity were measured to investigate
the direct participation of NO in the exercise-induced
expression of Hsp72 in the rat heart. Exercise alone did
not alter cardiac NOS or p-NOS content, possibly be-
cause we used a short-term exercise protocol, whereas
long-term exercise (4 to 10 weeks) increases NOS and
p-NOS expression in the rat myocardium [15, 16]. Re-
gardless, our results have shown that exercise-induced
content of cardiac Hsp72 increased in rats under inhibi-
tion of NOS. Therefore, expression of this heat shock
protein due to exercise seems not to depend on NO.
The in situ regulation of NOS expression and activ-
ity seems to be complex. For example, cardiac or vascu-
lar eNOS activity may involve multi-site phosphorylation
of serine/threonine residues [29, 30]. The induction of
stimulatory p-NOS may be counterbalanced by increas-
ing inhibitory p-NOS [31]. These results suggest that the
regulation of NOS-derived NO is complex because in-
creased NOS expression does not necessary mean in-
creased NOS activity, what may explain some of our find-
ings. For example, the inhibitory phosphorylation site
Ser852 was increased in the L group. However, total
nNOS content was also increased in this group, possibly
to compensate for the increased inhibition of nNOS ac-
tivity. Indeed, the L group had a NOS activity that was
similar to that in the other groups.
It is evident that acute L-NAME administration in-
hibits cardiac NOS activity [8, 32, 33], and chronic
L-NAME treatment increases blood pressure [24]. How-
ever, several studies have shown that rodents treated with
different L-NAME doses (from 1 to 50 mg.kg-1.day-1)
and durations (2 to 60 days) may exhibit compensatory
eNOS [19], nNOS [20], iNOS [20, 25] and total NOS
[34] expressions and activities in different tissues [20,
25], including the myocardium [19-21]. Together, these
results suggest that L-NAME treatment for days or
weeks may increase NOS expression and activity as a
compensatory mechanism.
However, in the EL group, inhibitory p-nNOSSer852
was decreased, while stimulatory phosphorylation site
Ser1177 on eNOS was increased. These results suggest
that NO production would be increased in the EL group.
However, cardiac NOS activity, as measured through a
more sensitive and specific method that converts
radiolabeled L-arginine to radiolabeled L-citrulline [35],
was similar in all the groups. Thus, it is possible that other
serine/threonine phosphorylation sites that were not as-
sessed in the present study are involved in steady-state
NO production. We could not find studies investigating
the effects of exercise and L-NAME on cardiac p-
eNOSSer1177 or p-nNOSSer852. Thus, further investigation
is necessary to explain this interaction.
Because cardiac NO production in the four groups
was apparently similar, the direct participation of NO in
exercise-induced cardiac Hsp72 content is unlikely. Why
L-NAME treatment enhances exercise-dependent car-
diac Hsp72 content is now a new and emerging question.
Increased cardiac afterload secondary to L-NAME
treatment did not appear to contribute to Hsp72 content,
because we did not find any correlation between Hsp72
content and arterial or ventricular pressure. Furthermore,
the EL group exhibited lower blood and ventricular pres-
sures than the L-NAME group. It has been suggested
that exercise prevents L-NAME-induced hypertension
[36]; however, the mechanisms responsible for this re-
sponse of the exercise need further study.
Given our results, myocardial Hsp72 elevated con-
tent induced by exercise and L-NAME cannot be ex-
plained by the same mechanism as myocardial Hsp72
content induced by exercise alone. First, Hsp72 content
was much higher in the EL group. Second, cardiac NO
production was similar in all groups. Third, the frequency
of rats that did not complete the exercise protocol was
higher in the EL group, suggesting more physical effort
and, consequently, earlier exhaustion. Fourth, animal deaths
only occurred in the EL group, suggesting the existence
of pathological stress.
Thus, it is likely that cardiac Hsp72 elevated con-
tent in rats simultaneously exercised and treated with
L-NAME is a response to pathological myocardial stress.
At least two mechanisms can be postulated to explain
this phenomenon: 1) ischemia-induced cardiac injury and
2) increased production of free radicals.
L-NAME treatment may induce a reduction in coro-
nary blood flow [18, 33] and subendocardial ischemia,
resulting in focal fibrosis and necrosis [19, 37]. Hypoxia
induces cardiac Hsp72 expression [38] as a mechanism
for preventing apoptosis [39]. It is possible that increased
Lunz/Capettini/Davel/Munhoz/Silva/Rossoni/Lemos/Baldo/Carneiro-
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exercise-induced myocardial oxygen demand [17] exac-
erbates the L-NAME-dependent ischemic effect. Indeed,
rats exercised for 8 weeks and treated with L-NAME
during the last 7 days of exercise days exhibited higher
cardiac fibrosis compared to rats subjected to L-NAME
treatment only [40].
Regarding free radicals, it is known that free radi-
cals induce Hsp72 [38, 41], and exercise may increase
free radicals in the myocardium [42]. It is also now known
that NOS produces superoxide anions (O2-) [43]. This
phenomenon, known as “NOS uncoupling”, increases the
levels of the potent oxidant peroxynitrite (ONOO-), which
induces protein nitration, DNA damage and cell death
[42]. In fact, it has been suggested that NO-induced pro-
tein damage is the cause of heat shock factor activation
[9]. Exercise-induced oxidative stress could generate
ONOO- through a direct reaction between mitochondrial
O2- and NO. Recently, Waard et al. showed that exer-
cise and elevated cardiac eNOS expression separately
attenuate LV dysfunction after myocardial infarction in
mice [44]. However, the combination of exercise and
eNOS overexpression abolished the beneficial effects of
each individual treatment, and this detrimental effect was
due to increased oxidative stress secondary to eNOS un-
coupling.
Although our results do not confirm the direct par-
ticipation of NO in cardiac Hsp72 expression, an indirect
contribution through ONOO- cannot be discounted. Ac-
cordingly, increased production of ONOO- could explain
the suggested NO-dependent Hsp72 overexpression ob-
served in other studies [6, 8, 9]. However, this hypothesis
needs to be addressed in further studies.
Ischemia-induced cardiac injury and/or increased pro-
duction of free radicals could also be responsible for the
high mortality of the rats subjected to exercise and simul-
taneously treated with L-NAME. Such a phenomenon
would characterize an important aspect of exercise intol-
erance.
Finally, we have to emphasize two study limitations.
The first is related to the L-NAME dose, since the ani-
mals were maintained in collective cages to reduce psy-
chological stress [22], the L-NAME dose was estimated
according to daily water consumption. However, the es-
timated L-NAME dose was close to values used in other
studies [19, 20, 24]. A second limitation was the mortality
in animals subjected to exercise under L-NAME treat-
ment, showing the importance of NO to acute exercise
adaptations. Mortality occurred out of the exercise train-
ing session. The mechanisms leading animals to death
deserves more detailed studies because our results may
represent only the effects in rats surviving to the combi-
nation of aerobic exercise under L-NAME effect.
In summary, our results showed that short-term
L-NAME treatment alone seems not to affect the myo-
cardial Hsp72 expression in rats. When L-NAME is used
concomitantly with aerobic exercise, it enhances the
myocardial content of this stress protein probably because
the exercise in presence of reduced NO production may
represent a greater stress to myocardium, including de-
velopment of pathological stress. Because exercise alone
increased cardiac Hsp72 content and did not change car-
diac NOS content or cardiac NO production, the exer-
cise-induced Hsp72 expression in the heart seems to be
unrelated to the direct participation of NO.
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